These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23237385)

  • 1. The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?
    Searles A; Doran E; Faunce TA; Henry D
    Aust Health Rev; 2013 Feb; 37(1):32-40. PubMed ID: 23237385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay.
    Groves S; Cohen D; Alam MF; Dunstan FD; Routledge PA; Hughes DA; Myles S
    Int J Pharm Pract; 2010 Dec; 18(6):332-40. PubMed ID: 21054593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical Benefits Scheme cost sharing, patient cost consciousness and prescription affordability.
    Doran E; Robertson J; Salkeld G
    Aust Health Rev; 2011 Feb; 35(1):37-44. PubMed ID: 21367329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumers.
    Whitty JA; Sav A; Kelly F; King MA; McMillan SS; Kendall E; Wheeler AJ
    Aust Health Rev; 2014 Nov; 38(5):589-95. PubMed ID: 25099307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of prescription charges on people living in poverty: A qualitative study.
    Norris P; Tordoff J; McIntosh B; Laxman K; Chang SY; Te Karu L
    Res Social Adm Pharm; 2016; 12(6):893-902. PubMed ID: 26681431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.
    Hynd A; Roughead EE; Preen DB; Glover J; Bulsara M; Semmens J
    Pharmacoepidemiol Drug Saf; 2008 Nov; 17(11):1091-9. PubMed ID: 18942671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Older people's perceptions of prescription medicine costs and related costs: a pilot study in New Zealand.
    Tordoff J; Bagge M; Ali F; Ahmed S; Choong JN; Fu R; Joe A; Nishtala P
    J Prim Health Care; 2014 Dec; 6(4):295-303. PubMed ID: 25485325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Travelling all over the countryside: travel-related burden and financial difficulties reported by cancer patients in New South Wales and Victoria.
    Zucca A; Boyes A; Newling G; Hall A; Girgis A
    Aust J Rural Health; 2011 Dec; 19(6):298-305. PubMed ID: 22098213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who uses complementary and alternative therapies in regional South Australia? Evidence from the Whyalla Intergenerational Study of Health.
    D'Onise K; Haren MT; Misan GM; McDermott RA
    Aust Health Rev; 2013 Feb; 37(1):104-11. PubMed ID: 23157874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinician identification of chronically ill patients who have problems paying for prescription medications.
    Heisler M; Wagner TH; Piette JD
    Am J Med; 2004 Jun; 116(11):753-8. PubMed ID: 15144912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of health insurance coverage in women's access to prescription medicines.
    Ranji UR; Wyn R; Salganicoff A; Yu H
    Womens Health Issues; 2007; 17(6):360-6. PubMed ID: 18042485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Older people's attitudes towards their regular medicines.
    Bagge M; Tordoff J; Norris P; Heydon S
    J Prim Health Care; 2013 Sep; 5(3):234-42. PubMed ID: 23998174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania.
    Yohana E; Kamuhabwa A; Mujinja P
    East Afr J Public Health; 2011 Mar; 8(1):52-7. PubMed ID: 22066285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins.
    McRae I; van Gool K; Hall J; Yen L
    Appl Health Econ Health Policy; 2017 Oct; 15(5):625-634. PubMed ID: 28660496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription medication cost-related non-adherence among Medicare CAHPS respondents: disparity by Hispanic ethnicity.
    Frankenfield DL; Wei II; Anderson KK; Howell BL; Waldo D; Sekscenski E
    J Health Care Poor Underserved; 2010 May; 21(2):518-43. PubMed ID: 20453354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-related barriers to use of health services and prescription medicines in Finland: a cross-sectional survey.
    Aaltonen K; Miettinen J; Airio I; Martikainen JE; Saastamoinen LK; Bell JS; Hartikainen S; Norris P
    Eur J Public Health; 2015 Jun; 25(3):368-72. PubMed ID: 25395397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economic burden of prescription drug use among elderly patients in Ponce, Puerto Rico.
    López-Negrón L; Monsanto-Planadeball HA
    P R Health Sci J; 2006 Jun; 25(2):149-53. PubMed ID: 17203713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between older adults' knowledge of their drug coverage and medication cost problems.
    Piette JD; Heisler M
    J Am Geriatr Soc; 2006 Jan; 54(1):91-6. PubMed ID: 16420203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.